Therapies

The latest in cardiology therapies and management

Latest Therapies Articles

Calcium Sensitizer Offers No Hemodynamic Benefit After Cardiac Surgery

Calcium Sensitizer Offers No Hemodynamic Benefit After Cardiac Surgery

Low-dose levosimendan in addition to standard care did not result in lower 30-day mortality compared with placebo in patients requiring hemodynamic support post-cardiac surgery.

Promising Phase 3 Study Results for Catecholamine Resistant Hypotension Mean Arterial Pressure

Promising Phase 3 Study Results for Catecholamine Resistant Hypotension Mean Arterial Pressure

A positive phase 3 study showed that patients treated with LJPC-501 were likely to achieve pre-specified blood pressure targets vs placebo.

Mexiletine Reduces Arrhythmic Events for Long QT Syndrome Type 3 Patients

Mexiletine Reduces Arrhythmic Events for Long QT Syndrome Type 3 Patients

Mexiletine significantly reduced life-threatening arrhythmic events in long QT syndrome type 3 patients.

Statin Therapy Does Not Prevent Acute Kidney Injury Following Cardiac Surgery

Statin Therapy Does Not Prevent Acute Kidney Injury Following Cardiac Surgery

Acute kidney injury occurred in 20.8% of the atorvastatin group and 19.5% of the placebo group, indicating that initiating perioperative statin therapy does not prevent AKI following cardiac surgery.

Early Beta-Blocker Administration Reduces In-Hospital Mortality in Acute Coronary Syndromes

Early Beta-Blocker Administration Reduces In-Hospital Mortality in Acute Coronary Syndromes

Researchers found that when oral beta-blockers were administered less than 24 hours after hospital admission, in-hospitality mortality and severe left ventricular dysfunction were both reduced.

N-3 Polyunsaturated Fatty Acids Reduces Risk of All-Cause Mortality in Myocardial Infarction

N-3 Polyunsaturated Fatty Acids Reduces Risk of All-Cause Mortality in Myocardial Infarction

N-3 polyunsaturated fatty acid use is associated with reduced risk of all-cause mortality and recurrent acute myocardial infarction.

ACE Inhibitors May Not Be as Effective in Black Patients

ACE Inhibitors May Not Be as Effective in Black Patients

Black patients may be less response to antihypertensive treatment with angiotensin-converting enzyme inhibitors than white patients.

FreezeAF: Cryoballoon Noninferior to Radiofrequency Ablation for Paroxysmal Atrial Fibrillation

FreezeAF: Cryoballoon Noninferior to Radiofrequency Ablation for Paroxysmal Atrial Fibrillation

Recent trials have shown that cryoballoon catheter ablation has demonstrated success in treating atrial fibrillation among 74% of patients, presenting an alternative to traditional radiofrequency ablation.

FDA Approves Entresto for Systolic Heart Failure

FDA Approves Entresto for Systolic Heart Failure

Intended to reduce risk of cardiovascular death and heart failure-related hospitalization, the FDA has approved Entresto.

Improved Perceived Mobility for Post-Stroke Upper Limb Dysfunction with Home-Based CIMT

Improved Perceived Mobility for Post-Stroke Upper Limb Dysfunction with Home-Based CIMT

Self-reported quality-of-movement scores improved among patients who underwent home-based constraint-induced movement therapy (CIMT) compared with those receiving standard care.

Sign Up for Free e-Newsletters